Antitrust
Viewpoints
Filter by:
AI: The Washington Report — National Priorities for Artificial Intelligence
June 8, 2023 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry
June 6, 2023 | Blog | By Bruce Sokler, Joseph Miller, Robert Kidwell, Payton Thornton
FTC Sends Notice of Potential Penalties to Approximately 670 Companies Regarding Substantiation of Advertising Claims
April 13, 2023 | Blog | By Bruce Sokler, Joanne Hawana, Robert Kidwell, Benjamin Zegarelli
Unanimous Federal Trade Commission Orders Illumina, Inc. to Divest GRAIL, Inc.
April 5, 2023 | Blog | By Bruce Sokler, Payton Thornton
DOJ Antitrust Division Announces Indictment Against Health Care Staffing Executive For Nurse Wage-Fixing
March 16, 2023 | Blog | By Bruce Sokler, Payton Thornton
Federal Trade Commission Continues Policy Initiatives by Seeking Public Comment on Franchisor-Franchisee Relationships
March 10, 2023 | Blog | By Bruce Sokler, Payton Thornton
DOJ Sues Google for Monopolizing Digital Advertising Markets
February 22, 2023 | Blog | By Joseph Miller, Tinny Song
Federal Judge Allows Antitrust Claims to Proceed Against Hospital System and Vertically-Integrated Physician Group
February 21, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
Out with the Old: The Antitrust Division Withdraws Healthcare Enforcement Policy Statements
February 7, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
FTC Invokes New and Expanded Powers to Propose Bar on Employee Non-Competes
January 9, 2023 | Alert | By Bruce Sokler, Joseph Miller, Charles Samuels, Evelyn French
New Law Hikes HSR Merger Filing Fees for Large Deals and Imposes Foreign Subsidy Disclosure Requirement
January 3, 2023 | Alert | By Bruce Sokler, Joseph Miller, Robert Kidwell, Farrah Short
Is Antitrust ESG's Achilles Heel ? House Republicans Think So.
December 13, 2022 | Blog | By Bruce Sokler, Jacob Hupart, Tinny Song, Payton Thornton
On the Board: DOJ Gets First Win in Criminal No-Poach Prosecution
October 31, 2022 | Blog | By Bruce Sokler, Tinny Song, Payton Thornton
DOJ Makes Good on Promise to Review Interlocking Directorates
October 21, 2022 | Blog | By Bruce Sokler, Robert Kidwell, Payton Thornton
The Department of Justice Antitrust Division (“DOJ”) recently announced that it has required several directors to resign from simultaneously serving on the corporate boards of competitor companies.
Read more
In Divided 3-2 Vote, Federal Trade Commission Authorizes Three Omnibus Compulsory Process Resolutions
August 30, 2022 | Blog | By Evelyn French, Bruce Sokler
FTC Policy Paper Supports Agency’s Long-Held Position in Opposition to COPAs
August 18, 2022 | Alert | By Bruce Sokler, Joseph Miller, Farrah Short
The NLRB’s Busy July – A Harbinger of Future Coordinated Federal Action Between the NLRB, FTC, and DOJ
August 15, 2022 | Blog | By Evan Piercey, Tinny Song, Richard Block
"Fowl" Play: DOJ Files Lawsuit and Proposed Consent Decrees with Poultry Processors over Wage Suppression Conspiracy
August 2, 2022 | Blog | By Bruce Sokler, Joseph Miller, Tinny Song
5th Circuit Confirms Avanci SEP Pool is Safe: No Antitrust Issue with Avanci’s Pool
July 6, 2022 | Blog | By Daniel Weinger, Michael Renaud, Bruce Sokler, James Thomson
DOJ and FTC Virtual Workshop: Agencies Discuss Novel Approaches to Address Competition Issues in Pharmaceutical Mergers
June 23, 2022 | Blog | By Evelyn French, Tinny Song
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology